{"DataElement":{"publicId":"14435684","version":"1","preferredName":"Adverse Event Domain Multi-agent Therapeutic Regimens Relationship Type","preferredDefinition":"The type of adverse event-related multi-agent therapy.","longName":"7190126v1.00:14429712v1.00","context":"AMC","contextVersion":"1","DataElementConcept":{"publicId":"7190126","version":"1","preferredName":"Adverse Event Domain Multi-agent Therapeutic Regimens Relationship","preferredDefinition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to an adverse event._A course of drugs that contain multiple substances._A state of connectedness between people, objects, or events; to be associated or connected with something.","longName":"2514626v1.0:7190130v1.0","context":"Theradex","contextVersion":"1","ObjectClass":{"publicId":"2514626","version":"1","preferredName":"Adverse Event Submission Domain","preferredDefinition":"No Value Exists","longName":"C49562","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adverse Event Domain","conceptCode":"C49562","definition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to an adverse event.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1BB1AAFE-FB2D-4FE3-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-08-23","modifiedBy":"ONEDATA","dateModified":"2006-08-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7190130","version":"1","preferredName":"Multi-agent Therapeutic Regimens Relationship","preferredDefinition":"A course of drugs that contain multiple substances.:A state of connectedness between people, objects, or events; to be associated or connected with something.","longName":"C160952:C25648","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Multi-agent Therapeutic Regimens","conceptCode":"C160952","definition":"A course of drugs that contain multiple substances.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Relationship","conceptCode":"C25648","definition":"A state of connectedness between people, objects, or events; to be associated or connected with something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A01F5F92-676E-50CC-E053-F662850A81CE","latestVersionIndicator":"Yes","beginDate":"2020-03-05","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-03-05","modifiedBy":"ONEDATA","dateModified":"2020-03-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A01F7902-BE6B-58F5-E053-F662850A9D77","latestVersionIndicator":"Yes","beginDate":"2020-03-05","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-03-05","modifiedBy":"TAYLORT","dateModified":"2020-03-05","changeDescription":"3-5-20 tmt created for Seed Study.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"14429712","version":"1","preferredName":"Type","preferredDefinition":"Something distinguishable as an identifiable class based on common qualities.","longName":"14429712v1.00","context":"AMC","contextVersion":"1","type":"Enumerated","dataType":"ALPHANUMERIC","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Leukapheresis","valueDescription":null,"ValueMeaning":{"publicId":"2579318","version":"1","preferredName":"Leukapheresis","longName":"2579318","preferredDefinition":"Removal of the blood to collect specific blood cells; the remaining blood is returned to the body.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Leukapheresis","conceptCode":"C15269","definition":"A procedure that collects white blood cells from the peripheral blood while returning the rest to the donor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-02E3-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-05-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-05-18","modifiedBy":"KUMMEROA","dateModified":"2023-08-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"03CB7AA2-88ED-74BA-E063-731AD00AEDA5","beginDate":"2023-08-25","endDate":null,"createdBy":"TSESU","dateCreated":"2023-08-25","modifiedBy":"TSESU","dateModified":"2023-08-25","deletedIndicator":"No"},{"value":"Conditioning","valueDescription":null,"ValueMeaning":{"publicId":"14429713","version":"1","preferredName":"Conditioning Chemotherapy","longName":"14429713v1.00","preferredDefinition":"Chemotherapy used before transplantation to destroy a patient's cancer cells and provide immunosuppression.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Conditioning Chemotherapy","conceptCode":"C188745","definition":"Chemotherapy used before transplantation to destroy a patient's cancer cells and provide immunosuppression.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"03CB7AA2-88EC-74BA-E063-731AD00AEDA5","latestVersionIndicator":"Yes","beginDate":"2023-08-25","endDate":null,"createdBy":"TSESU","dateCreated":"2023-08-25","modifiedBy":"TSESU","dateModified":"2023-08-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"03CB7AA2-88EE-74BA-E063-731AD00AEDA5","beginDate":"2023-08-25","endDate":null,"createdBy":"TSESU","dateCreated":"2023-08-25","modifiedBy":"TSESU","dateModified":"2023-08-25","deletedIndicator":"No"},{"value":"Infusion","valueDescription":null,"ValueMeaning":{"publicId":"2574004","version":"1","preferredName":"INFUSION","longName":"2574004","preferredDefinition":"INFUSION","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Infusion Procedure","conceptCode":"C15388","definition":"Any form of treatment that is introduced into the body via a blood vessel, a muscle, or the spinal cord.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EE21-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-08-08","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-08-08","modifiedBy":"TSESU","dateModified":"2023-08-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"03CB7AA2-88EF-74BA-E063-731AD00AEDA5","beginDate":"2023-08-25","endDate":null,"createdBy":"TSESU","dateCreated":"2023-08-25","modifiedBy":"TSESU","dateModified":"2023-08-25","deletedIndicator":"No"},{"value":"Other","valueDescription":null,"ValueMeaning":{"publicId":"2559653","version":"1","preferredName":"Other","longName":"2559653","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B612-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"GDEEN","dateModified":"2023-12-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"03CB7AA2-88F0-74BA-E063-731AD00AEDA5","beginDate":"2023-08-25","endDate":null,"createdBy":"TSESU","dateCreated":"2023-08-25","modifiedBy":"TSESU","dateModified":"2023-08-25","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"03CB6A6C-7673-7038-E063-731AD00A5E9B","latestVersionIndicator":"Yes","beginDate":"2023-08-25","endDate":null,"createdBy":"TSESU","dateCreated":"2023-08-25","modifiedBy":"TSESU","dateModified":"2023-08-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"AERELTO","type":"OID, AMC","context":"AMC"}],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"Adverse Event-related therapy type:","url":null,"context":"AMC"},{"name":"AMC CRF Text 1","type":"Alternate Question Text","description":"Related To","url":null,"context":"AMC"}],"origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"0400EF38-6278-7EAE-E063-731AD00AA0AD","latestVersionIndicator":"Yes","beginDate":"2023-08-28","endDate":null,"createdBy":"TSESU","dateCreated":"2023-08-28","modifiedBy":"TSESU","dateModified":"2023-08-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}